Nurse Mollie Charles, thats great
Lilly's oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions [press release]
It affects 1923% of adults at higher doses in clinical trials, peaking during dose-escalation weeks, and runs roughly 23 times higher than placebo across every dose group
30mg Melanotan 2 (3 vials) does not include water to mix Use this related resource when you want the next practical detail around 30mg Melanotan 2 (3 vials) does
This double-blind, placebo-controlled study randomized adults with a BMI 30 or 27 plus at least one obesity-related comorbidity (excluding diabetes) who had achieved 5% weight loss after 12 weeks of lifestyle modification to receive tirzepatide or placebo weekly for 72 weeks
Bariatric surgery is less scalable than GLP-1 medications, and people with obesity who have access to bariatric surgery are likely to choose GLP-1 medications